TotalMarketCap

Ernexa Therapeutics

ERNANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.020 M

$1.85 -7.03%

Close of 6 Nov 2026

As of 6 Nov 2026, Ernexa Therapeutics (ERNA) has a market capitalization of $3.02M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$582.0K

#3502 by revenue

Earnings

-$14.1M

Loss-making

Shares outstanding

1,692,550

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Ernexa Therapeutics lists more than one class of stock. Company figures above cover all classes combined.

ERNAW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #468OnconetixONCO$3.27M
  2. #46960 Degrees PharmaceuticalsSXTP$3.18M
  3. #470Ernexa TherapeuticsERNA$3.02M
  4. #471Mustang BioMBIO$2.99M
  5. #472Kala BioKALA$2.95M

What if Ernexa Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$17,297,652

Per share 9,350,082× higher

Bitcoin $1.53T

$935,945.82

Per share 505,917× higher

Apple $5.02T

$3,072,623

Per share 1,660,877× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Ernexa Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.